OptimizeRx (OPRX) Short term Debt (2010 - 2026)

OptimizeRx has disclosed Short term Debt across 8 years of filings, most recently posting $1.2 million for Q2 2026.

• In Q2 2026, Short term Debt fell 62.12% year-over-year to $1.2 million; the TTM figure through Jun 2026 stood at $1.2 million (down 62.12% YoY), while the FY2025 annual figure was $4.3 million, up 112.75% from the prior year.
• Short term Debt came in at $1.2 million for Q2 2026 at OptimizeRx, down from $2.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $4.3 million in Q4 2025 to a low of $1.2 million in Q2 2026.
• Average Short term Debt over 4 years is $2.7 million, with a median of $3.3 million recorded in 2024.
• Year-over-year, Short term Debt surged 112.75% in 2025 and tumbled 62.12% in 2026.
• Over 4 years, Short term Debt stood at $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then surged by 112.75% to $4.3 million in 2025, then sank by 70.62% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Short term Debt figures were $1.2 million in Q2 2026, $2.0 million in Q1 2026, and $4.3 million in Q4 2025.